Benjamin Harshbarger
CIK 1653133 · Chief Legal Officer · last filed 2026-01-23
Benjamin Harshbarger is a Chief Legal Officer who has filed 24 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for ATXS, was dated Jan 23, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
24
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) Delisted | Chief Legal Officer | — | $12.58 | — | $0 | 5 | 2026-01-23 |
| Astria Therapeutics, Inc. (CATB) Delisted | Chief Legal Officer | — | $8.54 | — | $0 | 3 | 2021-06-10 |
| NOVELION THERAPEUTICS INC. (NVLN) Delisted | See Remarks | 3,683 | — | — | $0 | 10 | 2019-05-13 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | General Counsel and Secretary | 0 | — | — | $0 | 5 | 2016-11-30 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-23 | Astria Therapeutics, Inc. (ATXS) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-03-25 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-12 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-06 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-03 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-02 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-12 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-13 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Tax (F) | −212 | -$259 | EDGAR |
| 2018-11-05 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Tax (F) | −570 | -$2.4K | EDGAR |